AHL Partners’s Accendra Health ACH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
$547K Sell
28,944
-84,473
-74% -$1.87M 0.01% 1064
2017
Q3
$3.31M Sell
113,417
-299,091
-73% -$8.83M 0.06% 511
2017
Q2
$13.3M Buy
412,508
+21,682
+6% +$712K 0.28% 49
2017
Q1
$13.5M Buy
390,826
+300,583
+333% +$10.7M 0.3% 26
2016
Q4
$3.18M Sell
90,243
-59,894
-40% -$2.02M 0.1% 382
2016
Q3
$5.21M Buy
150,137
+9,183
+7% +$321K 0.19% 142
2016
Q2
$5.27M Buy
140,954
+112,506
+395% +$4.23M 0.28% 74
2016
Q1
$1.15M Sell
28,448
-94,373
-77% -$3.51M 0.07% 353
2015
Q4
$4.42M Buy
122,821
+80,973
+193% +$2.93M 0.34% 88
2015
Q3
$1.34M Buy
+41,848
New +$1.42M 0.21% 175
2014
Q4
Sell
-98,154
Closed -$3.21M 781
2014
Q3
$3.21M Buy
+98,154
New +$3.34M 0.25% 155

Other funds holding ACH

AHL Partners's ACH Position: Q4 2017 in Review

AHL Partners reduced its Accendra Health (ACH) stake by 74% in Q4 2017, selling an estimated $1.87M and leaving 28,944 shares worth $547K. The position accounts for 0.01% of the portfolio, ranked #1064.

AHL Partners first reported a position in ACH in Q3 2014 and has held it in 11 quarters since. The position peaked at $13.5M in Q1 2017. 230 funds tracked by Wall St. Rank hold ACH as of Q4 2017.

  • AHL Partners held 28,944 shares of Accendra Health worth $547K as of Q4 2017.
  • AHL Partners sold 84,473 Accendra Health shares in Q4 2017, an estimated $1.87M.
  • Accendra Health made up 0.01% of AHL Partners's portfolio in Q4 2017, its #1064 holding.
  • AHL Partners first reported a position in Accendra Health in Q3 2014 and has held it in 11 quarters since.
  • AHL Partners's Accendra Health position peaked at $13.5M in Q1 2017.
  • 230 funds tracked by Wall St. Rank held Accendra Health as of Q4 2017.

Based on AHL Partners's 13F filing for Q4 2017, filed 14 Feb 2018.